Also trades as: 0R1F.L (LSE) · $vol 1M · BRM.DE (XETRA) · $vol 0M · BMY.SW (SIX) · $vol 0M

$59.46

-0.09 (-0.15%)

Weekly Expected Move ±3.9%

$53 $55 $57 $59 $61

NYSE · Healthcare · Drug Manufacturers - General · Alpha Radar Buy · Power 62 · $121.4B mcap · 2.04B float · 0.572% daily turnover · Short 56% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$48.2B -0.2% ▼

5Y CAGR: +2.5%

Gross Profit

$32.6B +18.8% ▲

5Y CAGR: +8.5%

Operating Income

$12.7B +31.5% ▲

5Y CAGR: +23.1%

Net Income

$7.1B +178.8% ▲

EPS (Diluted)

$3.45 +178.2% ▲

EBITDA

$14.5B +359.1% ▲

5Y CAGR: +24.2%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$46.4B	$46.2B	$45.0B	$48.3B	$48.2B
YoY Growth	+9.1%	-0.5%	-2.5%	+7.3%	-0.2%
Cost of Revenue	$19.6B	$19.7B	$19.6B	$20.9B	$15.6B
Gross Profit	$26.8B	$26.5B	$25.4B	$27.4B	$32.6B
Gross Margin	57.7%	57.4%	56.3%	56.8%	67.6%
R&D Expenses	$9.5B	$9.4B	$9.2B	$9.8B	$9.6B
SG&A Expenses	$7.7B	$7.8B	$7.7B	$7.9B	$7.2B
Operating Expenses	$17.2B	$17.2B	$16.9B	$17.8B	$19.9B
Operating Income	$9.5B	$9.3B	$8.5B	$9.7B	$12.7B
Operating Margin	20.6%	20.1%	18.8%	20.0%	26.3%
Interest Expense	$1.3B	$1.2B	$1.2B	$1.9B	$1.5B
Income Before Tax	$8.1B	$7.7B	$8.4B	-$8.4B	$9.3B
Tax Expense	$1.1B	$1.4B	$400M	$554M	$2.3B
Net Income	$7.0B	$6.3B	$8.0B	-$8.9B	$7.1B
Net Margin	15.1%	13.7%	17.8%	-18.5%	14.6%
EPS (Diluted)	$3.12	$2.95	$3.86	$-4.41	$3.45
EBITDA	$20.1B	$19.2B	$19.4B	$3.2B	$14.5B
Shares Outstanding	2.25B	2.15B	2.08B	2.03B	2.04B

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$12.2B	$11.9B	$12.3B	$11.2B	$12.3B	$12.2B	$12.5B	$11.5B
Cost of Revenue	$5.4B	$5.3B	$4.9B	$3.9B	$4.2B	$3.4B	$4.1B	$3.4B
Gross Profit	$6.8B	$6.6B	$7.4B	$7.3B	$8.1B	$8.8B	$8.4B	$8.1B
Gross Margin	55.7%	55.6%	60.2%	65.5%	65.8%	71.9%	67.2%	70.2%
R&D Expenses	$2.3B	$2.4B	$2.8B	$2.2B	$2.3B	$2.5B	$2.6B	$2.6B
SG&A Expenses	$1.9B	$2.0B	$1.9B	$1.6B	$1.7B	$1.8B	$2.2B	$1.6B
Operating Expenses	$4.2B	$4.3B	$4.9B	$3.8B	$4.0B	$5.1B	$7.0B	$4.8B
Operating Income	$2.6B	$2.3B	$2.5B	$3.5B	$4.1B	$3.6B	$1.4B	$3.3B
Operating Margin	21.2%	19.2%	20.5%	31.4%	33.6%	29.8%	11.4%	28.5%
Interest Expense	$521M	$505M	$496M	$494M	$485M	$480M	$51M	$0
Income Before Tax	$1.3B	$1.7B	$175M	$3.0B	$1.8B	$3.1B	$1.5B	$3.2B
Tax Expense	-$398M	$461M	$99M	$509M	$460M	$919M	$384M	$561M
Net Income	$1.7B	$1.2B	$72M	$2.5B	$1.3B	$2.2B	$1.1B	$2.7B
Net Margin	13.8%	10.2%	0.6%	21.9%	10.7%	18.0%	8.7%	23.3%
EPS (Diluted)	$0.83	$0.60	$0.04	$1.20	$0.64	$1.08	$0.53	$1.31
EBITDA	$4.4B	$4.8B	$2.6B	$4.5B	$3.3B	$4.6B	$2.2B	$3.7B
Shares Outstanding	2.03B	2.03B	2.04B	2.04B	2.04B	2.04B	2.04B	2.04B

BMY NYSE